IDV vehicle
36F79720D0169
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC FEDERAL SUPPLY SCHEDULE (36F797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $78.0M |
| Start date | Jul 15, 2020 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Aug 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 31 of 31 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2026 | P00030 | $0 | 65IB: SHORT-TERM CONTRACT EXTENSION OF FSS CONTRACT 36F79720D0169 |
| May 12, 2026 | P00028 | $0 | 65IB: SIN 42-2A - LIFE CYCLE CHANGE TO THE PERMANENT STAGE |
| May 12, 2026 | P00029 | $0 | 65IB: SHORT-TERM CONTRACT EXTENSION OF FSS CONTRACT 36F79720D0169 |
| Mar 10, 2026 | P00027 | $0 | 65IB - 42-2A PRODUCT DELETION - DISCONTINUED MANUFACTURING AND STOCK COMPLETELY EXHAUSTED |
| Mar 6, 2026 | P00026 | $0 | 65IB - LIFE CYCLE CHANGE FROM PROVISIONAL TO THE TEMPORARY STAGE - 42-2A |
| Jan 20, 2026 | P00025 | $0 | 65IB - SIN 42-2A PRODUCT ADDITION PROVISIONAL STAGE |
| Nov 19, 2025 | P00024 | $0 | 42-2A 2026 PUBLIC LAW 102-585 PRICING UPDATE (DUAL PRICING) |
| Sep 17, 2025 | P00023 | $0 | 65IB - SIN 42-2A PRODUCT ADDITION PERMANENT STAGE - TRANSFER FROM CTI BIOPHARMA CORP. |
| Apr 17, 2025 | P00022 | $0 | 65IB: SHORT-TERM CONTRACT EXTENSION |
| Mar 26, 2025 | P00021 | $0 | 65IB - PERMANENT PRICE DECREASES 42-2A - ALL FSS USERS |
| Dec 5, 2024 | P00020 | $0 | PL 2025 PRICING UPDATE |
| Oct 7, 2024 | P00019 | $0 | 65IB - 42-2A PRODUCT DELETION - DISCONTINUED MANUFACTURING AND STOCK COMPLETELY EXHAUSTED |
| Feb 21, 2024 | P00018 | $0 | 65IB - PERMANENT PRICE DECREASES 42-2A - ALL FSS USERS |
| Feb 14, 2024 | P00017 | $0 | 65IB - PRODUCT ADDITION PERMANENT STAGE - 42-2A - TRANSFER FROM AKARX, INC. |
| Dec 4, 2023 | P00016 | $0 | 2024 PL |
| Nov 1, 2023 | P00015 | $0 | 65IB - ADMINISTRATIVE MODIFICATION / NDC NUMBER CHANGE - SIN 42-2A |
| May 24, 2023 | P00014 | $0 | 65IB - PRODUCT DELETION 42-2A - NDC CHANGE |
| Nov 17, 2022 | P00013 | $0 | 2023 PUBLIC LAW 102-585 PRICING UPDATE |
| Sep 21, 2022 | P00012 | $0 | 65IB - NAC-CM PRICING CORRECTIVE CHANGE - CREDITS AND REBILLS |
| Jul 5, 2022 | P00011 | $0 | 65IB: ADMINISTRATIVE CHANGES - UPDATE COMPANY/ORDERING ADDRESS & POCS CONTACT NUMBER |
| Dec 28, 2021 | P00010 | $0 | PUBLIC LAW 2022. |
| Oct 26, 2021 | P00009 | $0 | 65IB - NDC CHANGE - SIN 42-2A |
| Sep 10, 2021 | P00008 | $0 | 65IB: PRODUCT ADDITION TRANSFER FROM AKCEA THERAPEUTICS - 42-2A |
| Aug 25, 2021 | P00007 | $0 | 65IB - LIFE CYCLE CHANGE FROM PRO-RATED TO INDEPENDENT STAGE |
| Jun 29, 2021 | P00005 | $0 | 65IB - NDC NUMBER CHANGE - SIN 42-2A |
| Jun 29, 2021 | P00006 | $0 | 65IB - PRODUCT ADDITION (NPS) - 42-2A |
| Mar 5, 2021 | P00004 | $0 | 65IB - ADMINISTRATIVE MODIFICATION NDC CHANGE - SIN 42-2B |
| Dec 18, 2020 | P00003 | $0 | P00003 PL 2021 TK#PL 21-0055 DUAL (CMB) |
| Dec 17, 2020 | P00002 | $0 | 65IB: ADMINISTRATIVE CHANGES - ORDERING & POINT OF CONTACT CHANGES |
| Sep 16, 2020 | P00001 | $0 | 65IB - PRODUCT ADDITION - PERMANENT STAGE - TRANSFER FROM ASTRAZENECA PHARMACEUTICAL LP 36F79719D0274 |
| Jul 6, 2020 | 0 | $0 | 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.